Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Device-Based Strategies for Guideline-Directed Therapy in Heart Failure
Author(s): Renzo Laborante , Attilio Restivo , Daniela Mele , et al Added: 6 months ago

Heart Failure

Prevention & Chronic Conditions
HFA 24: MONITOR-HF Subgroup Analysis
Author(s): Jasper J Brugts Added: 1 year ago
HFA 24 - We are joined by Dr Jasper J Brugts (Erasmus University Medical Centre, NL) to discuss the findings of a predefined subgroup analysis of the MONITOR-HF study (NTR7672).MONITOR-HF was an open-label, randomised trial, done in 25 centres in the Netherlands. Eligible patients had chronic heart failure of New York Heart Association class III and a previous heart failure hospitalisation,… View more

Heart Failure
Emerging Therapies for Obstructive Hypertrophic Cardiomyopathy
Author(s): Emily Li-Wen Chu , Daniel Seung Kim , Ahmad Masri Added: 1 week ago

Heart Failure

Intervention
ESC 24: The SENIOR RITA Trial
Author(s): Vijay Kunadian Added: 1 year ago
ESC Congress 2024 — No difference in cardiovascular outcomes between invasive and conservative strategies in elderly NSTEMI patients.Principal Investigator, Prof Vijay Kunadian (Newcastle upon Tyne Hospitals NHS Trust, UK) join us in London to discuss the key findings from the SENIOR RITA trial (NCT03052036; Newcastle-upon-Tyne Hospitals NHS Trust).The SENIOR-RITA trial is a multicenter, open… View more

Demographic

Prevention & Chronic Conditions
HFA 24: The TELESAT Study
Author(s): Nicolas Girerd Added: 1 year ago
HFA 2024 — Investigator, Prof Nicolas Girerd (University Hospital of Nancy, FR) joins us to discuss the findings from the TELESAT study (NCT06312501).This multicenter observational longitudinal cohort study investigated whether a Remote Patient Monitoring (RPM) program (Satelia®Cardio, Satelia) is able to prevent cardiac decompensation by detecting weak signals of decompensation early in patients… View more

Heart Failure

Digital Health
The Evolving Treatment Landscape for HFpEF in Cardiac Amyloidosis
Author(s): Added: 3 days ago
Dr Sarah Cuddy (Brigham and Women's Hospital, US) joins us to discuss the role of non-disease modifying treatments including SGLT2 inhibitors, mineralocorticoid receptor antagonists, GLP-1 receptor agonists, and implantable hemodynamic monitors in cardiac amyloidosis, and what this means for managing heart failure in this unique patient population.Interview Questions:Can you provide an overview… View more

Heart Failure
Congestion in Heart Failure
Author(s): Marko Kumric , Tina Ticinovic Kurir , Josko Bozic , et al Added: 1 year ago

Heart Failure
Job title: Medical Director
Flora Huang
Research Area(s) / Expertise: Job title: Non-Invasive Cardiologist
Dr Flora Huang obtained her medical degree from the University of British Columbia followed by internal medicine and cardiology training at the University of Toronto. She underwent additional subspecialty training in Advanced Echocardiography at St. Michael’s Hospital in Toronto. She is currently a non-invasive cardiologist at North York General Hospital in Toronto, Canada. View more
Rahul P Sharma
Research Area(s) / Expertise:

Intervention

Structural Intervention

 Job title: Interventional Cardiologist
Dr Rahul P Sharma is Professor of Medicine at Stanford University and an Interventional Cardiologist at Stanford Health Care, where he serves as Director of Structural Interventions and Associate Director of the Cardiac Catheterisation Laboratory.With over a decade of experience in complex coronary and structural heart interventions, he has combined clinical leadership with academic medicine,… View more